"Anabolic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.
| Descriptor ID |
D045930
|
| MeSH Number(s) |
D27.505.696.399.472.080
|
| Concept/Terms |
Anabolic Effect- Anabolic Effect
- Effect, Anabolic
- Anabolic Effects
- Effects, Anabolic
|
Below are MeSH descriptors whose meaning is more general than "Anabolic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anabolic Agents".
This graph shows the total number of publications written about "Anabolic Agents" by people in this website by year, and whether "Anabolic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 0 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anabolic Agents" by people in Profiles.
-
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects. Bone Res. 2024 Sep 05; 12(1):52.
-
Pharmacological and biological therapeutic strategies for osteogenesis imperfecta. Am J Med Genet C Semin Med Genet. 2016 12; 172(4):367-383.
-
Performance-Enhancing Substances. Adolesc Med State Art Rev. 2015 Apr; 26(1):174-88.
-
Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Lancet Oncol. 2015 Jan; 16(1):108-16.
-
Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility. Andrologia. 2015 Oct; 47(8):872-8.
-
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. Br J Haematol. 2014 Nov; 167(3):366-75.
-
A positive role for anabolic androgenic steroids: preventing metabolic syndrome and type 2 diabetes mellitus. Fertil Steril. 2014 Jul; 102(1):e5.
-
Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength. Osteoporos Int. 2014 Aug; 25(8):2097-107.
-
Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014 May; 101(5):1271-9.
-
Anabolic steroid induced hypogonadism in young men. J Urol. 2013 Dec; 190(6):2200-5.